B2DB — Who said what, where, and when

Laura Perez Benito

Senior Scientist, Janssen Pharmaceutica NV

Laura Perez Benito is listed as Senior Scientist, Janssen Pharmaceutica NV. Laura spoke at Drug Discovery Chemistry Europe 2026 in November 2026 (panellist, “Panel Discussion: How are AI/ML Techniques Impacting Drug Discovery in Pharma?”). Speaks mainly at Hospitals and Health Care events.

Compiled from published conference agendas; not yet confirmed by Laura. Is this you? Claim this profile.

About

Laura Perez Benito is a Principal Scientist at Johnson & Johnson with a strong background in molecular pharmacology and computational chemistry. She holds a Ph.D. focused on the study of G protein-coupled receptor (GPCR) oligomerization and the design of bivalent ligands using Physic-Based methods such Molecular Dynamics and Free energy perturbations, contributing to the understanding of receptor-receptor interactions and ligand targeting strategies. Following her doctoral work, she completed a postdoctoral fellowship at Johnson & Johnson, focused on the application of open-source software to perform free energy perturbation (FEP) and integrating FEP methodologies into early-stage drug discovery programs. This work advanced the use of computational tools in real-world pharmaceutical development. Currently, as a Principal Scientist at Johnson & Johnson, Laura continues to lead innovative efforts in applying computational methods to accelerate drug discovery and improve molec

Sessions at 1 conference

Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026

Spoke alongside

People who have shared a session with Laura at events on B2DB.